OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Revisiting potential druggable targets against SARS‐CoV ‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
Abdullah Al Mamun Sohag, Md. Abdul Hannan, Sadaqur Rahman, et al.
Drug Development Research (2020) Vol. 81, Iss. 8, pp. 919-941
Open Access | Times Cited: 42
Abdullah Al Mamun Sohag, Md. Abdul Hannan, Sadaqur Rahman, et al.
Drug Development Research (2020) Vol. 81, Iss. 8, pp. 919-941
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Qingxin Li, CongBao Kang
Microorganisms (2020) Vol. 8, Iss. 8, pp. 1250-1250
Open Access | Times Cited: 121
Qingxin Li, CongBao Kang
Microorganisms (2020) Vol. 8, Iss. 8, pp. 1250-1250
Open Access | Times Cited: 121
Hamster models of COVID-19 pneumonia reviewed: How human can they be?
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 68
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 68
Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises
Khandkar Shaharina Hossain, Md. Golzar Hossain, Akhi Moni, et al.
Heliyon (2020) Vol. 6, Iss. 12, pp. e05798-e05798
Open Access | Times Cited: 68
Khandkar Shaharina Hossain, Md. Golzar Hossain, Akhi Moni, et al.
Heliyon (2020) Vol. 6, Iss. 12, pp. e05798-e05798
Open Access | Times Cited: 68
Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID ‐19 prevention and cure
Mohammad Nazrul Islam, Khandkar Shaharina Hossain, Sourav Sarker, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1329-1344
Open Access | Times Cited: 67
Mohammad Nazrul Islam, Khandkar Shaharina Hossain, Sourav Sarker, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1329-1344
Open Access | Times Cited: 67
COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review
Youssef A. Attia, Mohamed T. El‐Saadony, Ayman A. Swelum, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 18, pp. 22241-22264
Open Access | Times Cited: 39
Youssef A. Attia, Mohamed T. El‐Saadony, Ayman A. Swelum, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 18, pp. 22241-22264
Open Access | Times Cited: 39
Repositioning Vitamin C as a Promising Option to Alleviate Complications associated with COVID-19
Mithila Farjana, Akhi Moni, Abdullah Al Mamun Sohag, et al.
Infection and Chemotherapy (2020) Vol. 52, Iss. 4, pp. 461-461
Open Access | Times Cited: 33
Mithila Farjana, Akhi Moni, Abdullah Al Mamun Sohag, et al.
Infection and Chemotherapy (2020) Vol. 52, Iss. 4, pp. 461-461
Open Access | Times Cited: 33
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28
Intestinal organoids: A versatile platform for modeling gastrointestinal diseases and monitoring epigenetic alterations
Mahsa Ghorbaninejad, Hamid Asadzadeh‐Aghdaei, Hossein Baharvand, et al.
Life Sciences (2023) Vol. 319, pp. 121506-121506
Closed Access | Times Cited: 11
Mahsa Ghorbaninejad, Hamid Asadzadeh‐Aghdaei, Hossein Baharvand, et al.
Life Sciences (2023) Vol. 319, pp. 121506-121506
Closed Access | Times Cited: 11
Papaverine, a promising therapeutic agent for the treatment of COVID‐19 patients with underlying cardiovascular diseases (CVDs)
Mehdi Valipour, Hamid Irannejad, Saeed Emami
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1246-1250
Open Access | Times Cited: 18
Mehdi Valipour, Hamid Irannejad, Saeed Emami
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1246-1250
Open Access | Times Cited: 18
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 9
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 9
Role and clinical implication of autophagy in COVID-19
Tianjiao Shan, Lanya Li, Jinming Yang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Tianjiao Shan, Lanya Li, Jinming Yang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Superiority of cilostazol among antiplatelet FDA ‐approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach
Mohammed A. Abosheasha, Afnan H. El‐Gowily
Drug Development Research (2020) Vol. 82, Iss. 2, pp. 217-229
Open Access | Times Cited: 22
Mohammed A. Abosheasha, Afnan H. El‐Gowily
Drug Development Research (2020) Vol. 82, Iss. 2, pp. 217-229
Open Access | Times Cited: 22
A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md Tawheed Hasan, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 18
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md Tawheed Hasan, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 18
Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2
Md. Asif Ahsan, Yongjing Liu, Cong Feng, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 714-725
Open Access | Times Cited: 19
Md. Asif Ahsan, Yongjing Liu, Cong Feng, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 714-725
Open Access | Times Cited: 19
Unravelling Insights into the Evolution and Management of SARS-CoV-2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
Structural, dynamic behaviour, in-vitro and computational investigations of Schiff’s bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein
Saeed Ullah, Atta Ullah, Muhammad Waqas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Saeed Ullah, Atta Ullah, Muhammad Waqas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Analysis of Promising Approaches to COVID-19 Vaccine Development
Г. Г. Онищенко, Т. Е. Сизикова, В. Н. Лебедев, et al.
Biological Products Prevention Diagnosis Treatment (2020) Vol. 20, Iss. 4, pp. 216-227
Open Access | Times Cited: 15
Г. Г. Онищенко, Т. Е. Сизикова, В. Н. Лебедев, et al.
Biological Products Prevention Diagnosis Treatment (2020) Vol. 20, Iss. 4, pp. 216-227
Open Access | Times Cited: 15
Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission
Tao Jin, Yong Xu, Chenwei Dai, et al.
AIP Advances (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 13
Tao Jin, Yong Xu, Chenwei Dai, et al.
AIP Advances (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 13
Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Ivan Malík, J Čiẑmárik, Mária Pecháčová, et al.
Česká a slovenská farmacie (2021) Vol. 70, Iss. 1, pp. 18-25
Closed Access | Times Cited: 12
Ivan Malík, J Čiẑmárik, Mária Pecháčová, et al.
Česká a slovenská farmacie (2021) Vol. 70, Iss. 1, pp. 18-25
Closed Access | Times Cited: 12
Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19
Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, et al.
Current Pharmaceutical Design (2021) Vol. 28, Iss. 12, pp. 948-968
Closed Access | Times Cited: 12
Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, et al.
Current Pharmaceutical Design (2021) Vol. 28, Iss. 12, pp. 948-968
Closed Access | Times Cited: 12
Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru
Percy Soto-Becerra, Carlos Culquichicón, Yamilée Hurtado-Roca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 12
Percy Soto-Becerra, Carlos Culquichicón, Yamilée Hurtado-Roca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 12
State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2
Shoichi Tanimoto, Satoru Itoh, Hisashi Okumura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10358-10358
Open Access | Times Cited: 8
Shoichi Tanimoto, Satoru Itoh, Hisashi Okumura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10358-10358
Open Access | Times Cited: 8
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
Mohammed A. Abosheasha, Afnan H. El‐Gowily, Abdo A. Elfiky
Journal of Thrombosis and Thrombolysis (2021) Vol. 53, Iss. 2, pp. 273-281
Open Access | Times Cited: 9
Mohammed A. Abosheasha, Afnan H. El‐Gowily, Abdo A. Elfiky
Journal of Thrombosis and Thrombolysis (2021) Vol. 53, Iss. 2, pp. 273-281
Open Access | Times Cited: 9
Clinically available/under trial drugs and vaccines for treatment of SARS-COV-2
Avinash Kumar, Arpana Parihar, S. Nisar Basha, et al.
Elsevier eBooks (2022), pp. 451-488
Closed Access | Times Cited: 6
Avinash Kumar, Arpana Parihar, S. Nisar Basha, et al.
Elsevier eBooks (2022), pp. 451-488
Closed Access | Times Cited: 6
